EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biosensor-Based Detection of Calprotectin and Lactoferrin as Neutrophil-Derived Markers of Inflammatory Bowel Diseases: From Molecular Pathophysiology to Point-of-Care Platforms

Nikita Sitkov iD, Andrey Ryabko iD, Sergei Ivanov iD, Yuri Cheburkin iD, Alexey Kolobov iD, Diana Khasanova, Vladimir Nikolaev, Dmitrii Kaplun iD, Kamil Gareev iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27062692 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Nikita Sitkov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Micro and Nanoelectronics, Saint Petersburg Electrotechnical University "LETI", 197022 Saint Petersburg, Russia. Hauptthemen laut MEDLINE: Lactoferrin, Leukocyte L1 Antigen Complex, Biosensing Techniques, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases (IBD) are chronic, relapsing, immune-mediated disorders that require regular and preferably noninvasive monitoring of inflammatory activity. Fecal biomarkers of neutrophilic inflammation, namely calprotectin and lactoferrin, therefore represent key analytical targets for diagnosis and longitudinal disease management. Despite their widespread clinical use, existing publications predominantly address either their clinical relevance or individual technical solutions, without establishing a comprehensive engineering-translational framework for their biosensor-based implementation. This review bridges this gap by providing an integrative analysis of the molecular and biological nature of calprotectin and lactoferrin, the mechanisms underlying their appearance in fecal matrices, and the analytical constraints that directly influence the design of hybrid point-of-care (PoC) biosensor systems. We systematically compare major biosensing platforms, emphasizing sensor architecture, signal transduction mechanisms, and sample preparation strategies as critical determinants of sensitivity, selectivity, reproducibility, and clinical relevance. The novelty of this review lies in combining the pathophysiological context of neutrophilic inflammation with physicochemical and technological aspects of biosensor development, enabling a transition from laboratory prototypes to evaluation of real translational readiness. The practical significance resides in establishing a methodological basis for rational design of next-generation hybrid-integrated biosensor systems and outlining perspectives for digital analytics and artificial intelligence in clinically interpretable IBD monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactoferrinLeukocyte L1 Antigen ComplexBiosensing TechniquesInflammatory Bowel DiseasesNeutrophilsHumansBiomarkersPoint-of-Care SystemsFecesAnimals

Stichwörter der Autor:innen

antibodiesaptamersbiosensorscalprotectininflammatory bowel diseaseslabel-free detectionlactoferrinnanomaterialspeptidespoint-of-care testing

Substanzen

LactoferrinLeukocyte L1 Antigen ComplexBiomarkers

Autor:innen und Institutionen

  • Department of Micro and Nanoelectronics, Saint Petersburg Electrotechnical University "LETI", 197022 Saint Petersburg, Russia.
  • Institute of Power Electronics and Photonics, Saint Petersburg Electrotechnical University "LETI", 197022 Saint Petersburg, Russia.
  • Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.
  • Ioffe Institute, 194021 Saint Petersburg, Russia.
  • Saint Petersburg State Pediatric Medical University, 194100 Saint Petersburg, Russia.
  • Institute of Human Hygiene, Occupational Pathology and Ecology, 188663 Saint Petersburg, Russia.

ORCID-Profile: Nikita Sitkov, Andrey Ryabko, Sergei Ivanov, Yuri Cheburkin, Alexey Kolobov, Dmitrii Kaplun, Kamil Gareev

Förderung

  • Russian Science Foundation

Zitieren

APA

Sitkov, N., Ryabko, A., Ivanov, S., Cheburkin, Y., Kolobov, A., Khasanova, D., Nikolaev, V., Kaplun, D., & Gareev, K. (2026). Biosensor-Based Detection of Calprotectin and Lactoferrin as Neutrophil-Derived Markers of Inflammatory Bowel Diseases: From Molecular Pathophysiology to Point-of-Care Platforms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27062692

Vancouver

Sitkov N, Ryabko A, Ivanov S, Cheburkin Y, Kolobov A, Khasanova D, et al. Biosensor-Based Detection of Calprotectin and Lactoferrin as Neutrophil-Derived Markers of Inflammatory Bowel Diseases: From Molecular Pathophysiology to Point-of-Care Platforms. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27062692

BibTeX
@article{Sitkov2026,
  author = {Sitkov, Nikita and Ryabko, Andrey and Ivanov, Sergei and Cheburkin, Yuri and Kolobov, Alexey and Khasanova, Diana and Nikolaev, Vladimir and Kaplun, Dmitrii and Gareev, Kamil},
  title = {Biosensor-Based Detection of Calprotectin and Lactoferrin as Neutrophil-Derived Markers of Inflammatory Bowel Diseases: From Molecular Pathophysiology to Point-of-Care Platforms},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27062692}
}
Kostenlos starten →